Outcomes of hepatitis B surface antigenaemia in patients with incident end-stage renal disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Ae Jin | - |
dc.contributor.author | Lee, Jin Hwan | - |
dc.contributor.author | Ko, Kwang-Pil | - |
dc.contributor.author | Jung, Eul Sik | - |
dc.contributor.author | Choi, Byoung Ho | - |
dc.contributor.author | Ro, Han | - |
dc.contributor.author | Jung, Ji Yong | - |
dc.contributor.author | Lee, Hyun Hee | - |
dc.contributor.author | Chung, Wookyung | - |
dc.contributor.author | Chang, Jae Hyun | - |
dc.date.available | 2020-02-28T00:41:26Z | - |
dc.date.created | 2020-02-07 | - |
dc.date.issued | 2016-11 | - |
dc.identifier.issn | 1320-5358 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/7740 | - |
dc.description.abstract | Aim: Hepatitis B virus (HBV) infection is an important risk factor for morbidity and mortality in the general population. However, limited data are available on the progression of HBV infection in patients with end-stage renal disease (ESRD), and available data are controversial. Therefore, we investigated the association between hepatitis B surface antigen (HBsAg) seropositivity and mortality in patients with incident ESRD. Methods: All adult patients (>= 18 years of age) starting dialysis for ESRD from January 2000 to December 2011 were included. A total of 1090 patients with ESRD were analyzed. HBsAg-positive patients were paired 1: 6 with HBsAgnegative patients using propensity score matching. Results: Eighty one (7.4%) patients were HBsAg positive. No differences in the survival rates of the HBsAg-positive and HBsAg-negative patients with ESRD were detected in either the entire cohort or the propensity score matched cohort. No differences in survival were detected between the groups of HBsAgpositive patients based on the hepatitis B envelope antigen, hepatitis B envelope antibody, HBV DNA status, or use of antiviral agents. No difference in mortality was found between the haemodialysis (HD) and peritoneal dialysis (PD) subgroups among HBsAg-positive patients. Conclusion: Our results suggest that hepatitis B surface antigenaemia is not related to increased mortality in patients with incident ESRD. Survival of HBsAg-positive patients undergoing PD was comparable to that of patients undergoing HD. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.relation.isPartOf | NEPHROLOGY | - |
dc.subject | HEPATOCELLULAR-CARCINOMA | - |
dc.subject | INSULIN-RESISTANCE | - |
dc.subject | VIRAL-INFECTION | - |
dc.subject | VIRUS LOAD | - |
dc.subject | HEMODIALYSIS | - |
dc.subject | RISK | - |
dc.subject | DIALYSIS | - |
dc.subject | IMPACT | - |
dc.subject | MORTALITY | - |
dc.subject | CIRRHOSIS | - |
dc.title | Outcomes of hepatitis B surface antigenaemia in patients with incident end-stage renal disease | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000385715400009 | - |
dc.identifier.doi | 10.1111/nep.12687 | - |
dc.identifier.bibliographicCitation | NEPHROLOGY, v.21, no.11, pp.968 - 974 | - |
dc.identifier.scopusid | 2-s2.0-84990837302 | - |
dc.citation.endPage | 974 | - |
dc.citation.startPage | 968 | - |
dc.citation.title | NEPHROLOGY | - |
dc.citation.volume | 21 | - |
dc.citation.number | 11 | - |
dc.contributor.affiliatedAuthor | Kim, Ae Jin | - |
dc.contributor.affiliatedAuthor | Lee, Jin Hwan | - |
dc.contributor.affiliatedAuthor | Ko, Kwang-Pil | - |
dc.contributor.affiliatedAuthor | Jung, Eul Sik | - |
dc.contributor.affiliatedAuthor | Choi, Byoung Ho | - |
dc.contributor.affiliatedAuthor | Ro, Han | - |
dc.contributor.affiliatedAuthor | Jung, Ji Yong | - |
dc.contributor.affiliatedAuthor | Lee, Hyun Hee | - |
dc.contributor.affiliatedAuthor | Chung, Wookyung | - |
dc.contributor.affiliatedAuthor | Chang, Jae Hyun | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | end-stage renal disease | - |
dc.subject.keywordAuthor | haemodialysis | - |
dc.subject.keywordAuthor | hepatitis B virus | - |
dc.subject.keywordAuthor | mortality | - |
dc.subject.keywordAuthor | peritoneal dialysis | - |
dc.subject.keywordPlus | HEPATOCELLULAR-CARCINOMA | - |
dc.subject.keywordPlus | INSULIN-RESISTANCE | - |
dc.subject.keywordPlus | VIRAL-INFECTION | - |
dc.subject.keywordPlus | VIRUS LOAD | - |
dc.subject.keywordPlus | HEMODIALYSIS | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | DIALYSIS | - |
dc.subject.keywordPlus | IMPACT | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | CIRRHOSIS | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.